Literature DB >> 8938654

Endothelin-induced inositol phosphate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis.

K Becker1, W Erdbrügger, I Heinroth-Hoffmann, M C Michel, O E Brodde.   

Abstract

The aim of this study was to characterize the properties of endothelin (ET)-receptor subtypes mediating inositol phosphate (IP)-formation in rat kidney and their regulation during ontogenesis. In renal cortical slices of adult rats (12-16 weeks old) ET's concentration-dependently increased IP-formation with an order of potency ET-1 >> ET-3. While the non-selective ET-receptor antagonist bosentan (10 microM) completely suppressed ET-induced IP-formation, the ETA-receptor antagonist BQ-123 (10 microM) inhibited it only by 70%, the ETB-receptor antagonist IRL 1038 (1 microM) by 25%; combined application of BQ-123 + IRL 1038 caused complete inhibition of ET-1-induced IP-formation. Pretreatment of isolated renal cells with pertussis toxin (PTX, 500 ng/ml) overnight did not attenuate but significantly increased ET-1-induced IP-formation. Ontogenetic studies in renal sites from neonatal, 1, 2, 3, 6, 12 and 24 weeks old rats revealed that ET-1-induced IP-formation maturation-dependently declined being highest in neonatal rats (increase: 169% over basal) and lowest in 24 weeks old rats (increase: 47% over basal). This decline in ET-induced IP-formation was accompanied by a decrease in renal ET-receptor number and the amount of immunodetectable Gq/11 (assessed by Western-blotting using the QL-antiserum). Moreover, ET-receptor subtypes changed during the maturation process: from neonates to 12 weeks old rats number and functional responsiveness of ETA-receptors declined, while that of ETB-receptors increased. We conclude that in adult rat renal cortex ET-induced IP-formation is mediated by activation of both ETA- and ETB-receptors and does not involve a PTX-sensitive G-protein. ET-induced IP-formation declines during the maturation process; this is associated with a decrease in ET-receptor number and the immunodetectable amount of Gq/11.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938654     DOI: 10.1007/bf00170830

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

Review 1.  Endothelin peptides: biological activities, cellular signalling and clinical significance.

Authors:  J Leppäluoto; H Ruskoaho
Journal:  Ann Med       Date:  1992-06       Impact factor: 4.709

Review 2.  Blood pressure control--special role of the kidneys and body fluids.

Authors:  A C Guyton
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

3.  Localization of several G-protein subunits to the apical and basolateral membranes of cortical tubular cells from the rat kidney.

Authors:  I Van der Ploeg; B B Fredholm; M Carlquist; A Bertorello; A Aperia; G Celsi
Journal:  Acta Physiol Scand       Date:  1991-05

4.  Calculating receptor number from binding experiments using same compound as radioligand and competitor.

Authors:  A DeBlasi; K O'Reilly; H J Motulsky
Journal:  Trends Pharmacol Sci       Date:  1989-06       Impact factor: 14.819

Review 5.  The current endothelin receptor classification: time for reconsideration?

Authors:  W A Bax; P R Saxena
Journal:  Trends Pharmacol Sci       Date:  1994-10       Impact factor: 14.819

6.  Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis.

Authors:  W A Bax; A T Bruinvels; R J van Suylen; P R Saxena; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

7.  A low-affinity, low-molecular-mass endothelin-A receptor in neonatal rat heart.

Authors:  E A Woodcock; S L Land; R K Andrews; M Linsenmeyer; D M Woodcock
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

8.  An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21)

Authors:  Y Urade; Y Fujitani; K Oda; T Watakabe; I Umemura; M Takai; T Okada; K Sakata; H Karaki
Journal:  FEBS Lett       Date:  1992-10-12       Impact factor: 4.124

9.  Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan.

Authors:  B Hocher; P Rohmeiss; F Diekmann; R Zart; V Vogt; S Schiller; C Bauer; K Koppenhagen; A Distler; N Gretz
Journal:  Eur J Clin Chem Clin Biochem       Date:  1995-08

10.  Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors.

Authors:  M Takigawa; T Sakurai; Y Kasuya; Y Abe; T Masaki; K Goto
Journal:  Eur J Biochem       Date:  1995-02-15
View more
  1 in total

1.  Nitric oxide modulates renal vasoconstrictor effect of endothelin-1 in conscious lambs.

Authors:  Francine G Smith; Liesbeth van der Velde; Alp Sener
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.